Measurement of antibody-membrane interactions by surface plasmon resonance. 2004

Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
Department of Pharmaceutical Product Development, Fraunhofer IME, Worringerweg 1, 52074 Aachen, Germany.

Due to problems of immobilizing functional tumor antigens in their natural conformation on surfaces for immunoassays, it is often difficult to evaluate the binding of antibodies derived from phage display libraries depleted and selected by panning on cell lines and living tumor cells. Performing cell membrane based ELISA methods does not reveal any up front kinetic binding information and depends on the performance of secondary antibodies and substrates. To overcome these limitations, we developed a new method to visualize direct antibody-cell membrane interactions by surface plasmon resonance using the Biacore 3000 and on-line signal subtraction on antigen-negative cell membrane vesicles. Conditions for the coating of cell membrane preparations to a carboxymethyl dextran hydrogel surface of a commercially available chip and the proof of concept for this application by the analysis of different formats of anti-CD30 and anti-carcinoembryonic antigen (CEA) antibodies interacting with coated membrane vesicles of CD30-positive/CEA-negative and CD30-negative and CEA-positive cell lines are described.

UI MeSH Term Description Entries
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D017730 Ki-1 Antigen A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. Antigens, CD30,Antigens, Ki-1,Ber-H2 Antigens,CD30 Antigens,Ki-1 Antigens,Tumor Necrosis Factor Receptor Superfamily, Member 8,Ber-H2 Antigen,CD30 Antigen,TNFRSF8 Receptor,Antigen, Ber-H2,Antigen, CD30,Antigen, Ki-1,Antigens, Ber-H2,Antigens, Ki 1,Ber H2 Antigen,Ber H2 Antigens,Ki 1 Antigen,Ki 1 Antigens,Receptor, TNFRSF8
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020349 Surface Plasmon Resonance A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film's surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding. Plasmon Resonance, Surface,Plasmon Resonances, Surface,Resonance, Surface Plasmon,Resonances, Surface Plasmon,Surface Plasmon Resonances

Related Publications

Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
June 2006, Chemistry and physics of lipids,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 1999, Methods in molecular medicine,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
December 2023, ACS applied materials & interfaces,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 2005, Annali dell'Istituto superiore di sanita,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 2010, Methods in enzymology,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 1990, Journal of molecular recognition : JMR,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 2018, Advances in protein chemistry and structural biology,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 2003, Biochimie,
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
January 2012, Methods in molecular biology (Clifton, N.J.),
Alexander Klimka, and Mehmet K Tur, and Michael Huhn, and Uwe Bierfreund, and Estela Terrada, and Rainer Fischer, and Ricarda Finnern, and Stefan Barth
October 2001, Journal of biochemistry,
Copied contents to your clipboard!